Altre lingue Eli Lilly and Company Buenos Aires S.E.

Azioni

LLYD

ARDEUT111192

Prezzo di chiusura Buenos Aires S.E. Altri mercati azionari 00:00:00 31/05/2024			Variaz. 5gg	Var. 1 gen.
15,9 ^USD	-.--%		+0,95%	+46,45%

30/05	Il Governo danese attua regole di sovvenzione più severe per i farmaci per il diabete	MT
30/05	Il produttore di Wegovy, Novo Nordisk, fa causa a nove centri termali, cliniche e farmacie per i farmaci copiati	RE

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Danish Government Implements Stricter Subsidy Rules for Diabetes Drugs	30/05
Wegovy maker Novo Nordisk sues nine spas, clinics and pharmacies over copycat drugs	30/05
ELI LILLY AND COMPANY : Goldman Sachs optimiste sur le dossier	30/05
Eli Lilly's Retevmo Gets FDA Accelerated Approval for Kids With RET-altered Thyroid Cancer, Solid Tumors	29/05
Weight-loss drug forecasts jump to $150 billion as supply grows	28/05
Sector Update: Health Care Stocks Decline Late Friday Afternoon	24/05
Eli Lilly to Invest Another $5.3 Billion in Indiana Manufacturing Site	24/05
Sector Update: Health Care Stocks Softer in Friday Afternoon Trading	24/05
Sector Update: Health Care	24/05
Top Midday: Intuit, Workday Shares Tumble on Lowered Guidance; Ozempic Reduces Kidney Disease Events, Deaths From Cardiovascular Causes; NHTSA Finds 9 Additional Incidents Tied to Waymo	24/05
Eli Lilly More Than Doubles Investment in Indiana Manufacturing Site to $9 Billion	24/05
Eli Lilly More Than Doubles Investment in Indiana Manufacturing Site to $9 Billion	24/05
Eli Lilly and Company Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production forirzepatide and Pipeline Medicines	24/05
ELI LILLY AND COMPANY : Jefferies & Co. optimiste sur le dossier	24/05
Germany's Gerresheimer to acquire Blitz LuxCo for $866 mln	23/05
Swiss Equities Tumble as UK Inflation Data Dampens June Rate Cut Hopes	22/05
Australia to ban knock-offs of popular weight-loss drugs Ozempic, Mounjaro	22/05
Two US asset managers launch weight-loss ETFs	21/05
Sector Update: Health Care Stocks Steady Premarket Tuesday	21/05
Eli Lilly and Company's Phase 3 Study of Mirikizumab to Treat Crohn's Disease Achieves 'Meaningful Improvements'	21/05

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

In prima pagina

Il CEO di Eli Lilly sulla lotta all'obesità e lo sviluppo di nuovi farmaci

12 marzo 2024 alle 19:47